HIV-Infected Ugandan Women on Antiretroviral Therapy Maintain HIV-1 RNA Suppression Across Periconception, Pregnancy, and Postpartum Periods.
about
Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural UgandaTiming of pregnancy, postpartum risk of virologic failure and loss to follow-up among HIV-positive women.Implementation and Operational Research: Impact of a Systems Engineering Intervention on PMTCT Service Delivery in Côte d'Ivoire, Kenya, Mozambique: A Cluster Randomized Trial.Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's Option B+ ProgramProgram Implementation of Option B+ at a President's Emergency Plan for AIDS Relief-Supported HIV Clinic Improves Clinical Indicators But Not Retention in Care in Mbarara, Uganda.Offering pre-exposure prophylaxis for HIV prevention to pregnant and postpartum women: a clinical approachViral Suppression and Retention in Care up to 5 Years After Initiation of Lifelong ART During Pregnancy (Option B+) in Rural Uganda.Trends in one-year cumulative incidence of death between 2005 and 2013 among patients initiating antiretroviral therapy in Uganda.Pregnant and breastfeeding women: A priority population for HIV viral load monitoring.Viraemia before, during and after pregnancy in HIV-infected women on antiretroviral therapy in rural KwaZulu-Natal, South Africa, 2010-2015."I beg you…breastfeed the baby, things changed": infant feeding experiences among Ugandan mothers living with HIV in the context of evolving guidelines to prevent postnatal transmission.What is new in perinatal HIV prevention?HIV Infection and risk of postpartum infection, complications and mortality in rural Uganda.Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review.
P2860
Q28551309-B0AF77CF-2038-48C1-8336-587804363BE6Q33853679-219C6ABE-2FF5-4F39-BE46-DBEE97EF0732Q37014059-52C0FA7F-6AD0-4B5A-8D21-7ECDF0A73A66Q37339299-3186A435-85A9-4DA5-96B5-95B956B2915AQ38400358-2F83A09B-C965-4C9E-A741-AD4C5B79A0A1Q38737364-0B410BF6-BCD9-43D2-85EA-5FDEB32685DDQ38852269-8B7A63E5-CED6-4BA5-A78F-E6A825381A98Q38852957-6BE755A2-DE31-4BF0-AECB-291FE05DAF4EQ40082574-A489E159-6737-4E1C-ADED-BF136A35F435Q46187732-6B239C03-7941-402B-AF50-FE8800520B57Q47551028-CB707376-0A88-47F1-8F5F-504D86126DC2Q48521585-9EAE3D7D-C512-4595-B6DD-8101656BD019Q49943871-8A9CB03C-7DA0-4C39-BA13-CEC20AD3E809Q55513030-CB0A310E-11A2-4A59-B574-31C120F45461
P2860
HIV-Infected Ugandan Women on Antiretroviral Therapy Maintain HIV-1 RNA Suppression Across Periconception, Pregnancy, and Postpartum Periods.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 October 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HIV-Infected Ugandan Women on ...... nancy, and Postpartum Periods.
@en
HIV-Infected Ugandan Women on ...... nancy, and Postpartum Periods.
@nl
type
label
HIV-Infected Ugandan Women on ...... nancy, and Postpartum Periods.
@en
HIV-Infected Ugandan Women on ...... nancy, and Postpartum Periods.
@nl
prefLabel
HIV-Infected Ugandan Women on ...... nancy, and Postpartum Periods.
@en
HIV-Infected Ugandan Women on ...... nancy, and Postpartum Periods.
@nl
P2093
P2860
P921
P1476
HIV-Infected Ugandan Women on ...... nancy, and Postpartum Periods.
@en
P2093
Heather B Ribaudo
Jeffrey N Martin
Jerome Kabakyenga
Jessica E Haberer
Kara Bennett
Lynn T Matthews
Mark J Siedner
Nicholas Musinguzi
Peter W Hunt
P2860
P304
P356
10.1097/QAI.0000000000000874
P407
P577
2015-10-22T00:00:00Z